Annual Current Assets
$99.27 M
-$16.64 M-14.35%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total current assets is currently $99.27 million, with the most recent change of -$16.64 million (-14.35%) on 31 December 2023. During the last 3 years, it has risen by +$10.28 million (+11.56%). RIGL annual current assets is now -67.18% below its all-time high of $302.46 million, reached on 31 December 2012.RIGL Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$106.47 M
+$11.74 M+12.40%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total current assets is currently $106.47 million, with the most recent change of +$11.74 million (+12.40%) on 30 September 2024. Over the past year, it has increased by +$11.44 million (+12.04%). RIGL quarterly current assets is now -64.80% below its all-time high of $302.46 million, reached on 31 December 2012.RIGL Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.3% | +12.0% |
| 3 y3 years | +11.6% | -37.8% |
| 5 y5 years | -27.5% | -15.5% |
RIGL Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.7% | +11.6% | -37.8% | +15.1% |
| 5 y | 5 years | -35.7% | +11.6% | -45.9% | +19.6% |
| alltime | all time | -67.2% | +1063.7% | -64.8% | +314.6% |
Rigel Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $106.47 M(+12.4%) |
| June 2024 | - | $94.72 M(+2.4%) |
| Mar 2024 | - | $92.49 M(-6.8%) |
| Dec 2023 | $17.96 M(-2.3%) | $99.27 M(+4.5%) |
| Sept 2023 | - | $95.02 M(-5.8%) |
| June 2023 | - | $100.92 M(-5.7%) |
| Mar 2023 | - | $106.97 M(-7.7%) |
| Dec 2022 | $18.38 M(+42.9%) | $115.90 M(+4.9%) |
| Sept 2022 | - | $110.44 M(-8.4%) |
| June 2022 | - | $120.52 M(-13.3%) |
| Mar 2022 | - | $138.94 M(-10.1%) |
| Dec 2021 | $12.86 M(-39.9%) | $154.47 M(-9.7%) |
| Sept 2021 | - | $171.10 M(-7.1%) |
| June 2021 | - | $184.20 M(-6.4%) |
| Mar 2021 | - | $196.76 M(+121.1%) |
| Dec 2020 | $21.39 M(-25.1%) | $88.98 M(-10.9%) |
| Sept 2020 | - | $99.85 M(-11.7%) |
| June 2020 | - | $113.09 M(-2.8%) |
| Mar 2020 | - | $116.33 M(-2.2%) |
| Dec 2019 | $28.56 M(+1246.1%) | $119.00 M(-5.6%) |
| Sept 2019 | - | $126.00 M(+1.2%) |
| June 2019 | - | $124.50 M(-10.6%) |
| Mar 2019 | - | $139.32 M(+1.7%) |
| Dec 2018 | $2.12 M(+26.5%) | $136.99 M(+13.2%) |
| Sept 2018 | - | $121.04 M(-13.0%) |
| June 2018 | - | $139.06 M(+43.9%) |
| Mar 2018 | - | $96.62 M(-17.7%) |
| Dec 2017 | $1.68 M(-12.6%) | $117.43 M(+68.8%) |
| Sept 2017 | - | $69.56 M(-17.0%) |
| June 2017 | - | $83.79 M(-15.8%) |
| Mar 2017 | - | $99.52 M(+30.6%) |
| Dec 2016 | $1.92 M(-29.5%) | $76.21 M(-11.9%) |
| Sept 2016 | - | $86.55 M(-10.7%) |
| June 2016 | - | $96.90 M(-8.2%) |
| Mar 2016 | - | $105.61 M(-18.2%) |
| Dec 2015 | $2.72 M(-24.3%) | $129.02 M(-5.3%) |
| Sept 2015 | - | $136.18 M(-6.4%) |
| June 2015 | - | $145.52 M(-10.5%) |
| Mar 2015 | - | $162.52 M(+8.0%) |
| Dec 2014 | $3.60 M(-39.9%) | $150.54 M(-5.3%) |
| Sept 2014 | - | $158.94 M(-10.5%) |
| June 2014 | - | $177.54 M(-10.3%) |
| Mar 2014 | - | $197.83 M(-10.1%) |
| Dec 2013 | $5.98 M(-21.1%) | $220.07 M(-5.6%) |
| Sept 2013 | - | $233.01 M(-8.5%) |
| June 2013 | - | $254.58 M(-7.6%) |
| Mar 2013 | - | $275.40 M(-8.9%) |
| Dec 2012 | $7.58 M | $302.46 M(+62.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $186.63 M(-9.6%) |
| June 2012 | - | $206.37 M(-8.7%) |
| Mar 2012 | - | $226.07 M(-9.7%) |
| Dec 2011 | $6.87 M(+1.5%) | $250.23 M(-6.8%) |
| Sept 2011 | - | $268.59 M(-4.9%) |
| June 2011 | - | $282.57 M(+78.4%) |
| Mar 2011 | - | $158.43 M(-11.9%) |
| Dec 2010 | $6.77 M(+41.7%) | $179.93 M(-5.4%) |
| June 2010 | - | $190.11 M(-10.4%) |
| Mar 2010 | - | $212.29 M(+56.1%) |
| Dec 2009 | $4.78 M(-17.2%) | $135.97 M(-14.6%) |
| Sept 2009 | - | $159.14 M(+92.7%) |
| June 2009 | - | $82.58 M(-23.5%) |
| Mar 2009 | - | $108.00 M(-21.8%) |
| Dec 2008 | $5.77 M(+23.9%) | $138.09 M(-15.5%) |
| Sept 2008 | - | $163.40 M(-13.8%) |
| June 2008 | - | $189.57 M(-11.2%) |
| Mar 2008 | - | $213.46 M(+92.1%) |
| Dec 2007 | $4.66 M(-10.8%) | $111.13 M(-3.1%) |
| Sept 2007 | - | $114.72 M(-11.1%) |
| June 2007 | - | $129.04 M(+40.1%) |
| Mar 2007 | - | $92.14 M(-14.7%) |
| Dec 2006 | $5.23 M(+3.0%) | $108.01 M(-9.2%) |
| Sept 2006 | - | $118.92 M(-5.9%) |
| June 2006 | - | $126.33 M(-5.3%) |
| Mar 2006 | - | $133.40 M(-6.4%) |
| Dec 2005 | $5.07 M(+10.7%) | $142.60 M(+8.3%) |
| Sept 2005 | - | $131.70 M(+105.3%) |
| June 2005 | - | $64.16 M(-15.2%) |
| Mar 2005 | - | $75.67 M(+1.9%) |
| Dec 2004 | $4.58 M(-15.3%) | $74.24 M(-0.9%) |
| Sept 2004 | - | $74.92 M(-12.8%) |
| June 2004 | - | $85.89 M(-11.9%) |
| Mar 2004 | - | $97.45 M(+94.5%) |
| Dec 2003 | $5.41 M(-27.7%) | $50.11 M(-17.1%) |
| Sept 2003 | - | $60.47 M(-0.2%) |
| June 2003 | - | $60.60 M(+136.0%) |
| Mar 2003 | - | $25.68 M(-30.3%) |
| Dec 2002 | $7.48 M(-24.6%) | $36.86 M(-6.3%) |
| Sept 2002 | - | $39.35 M(-25.6%) |
| June 2002 | - | $52.86 M(-17.0%) |
| Mar 2002 | - | $63.67 M(+74.3%) |
| Dec 2001 | $9.91 M(+3.5%) | $36.53 M(-13.8%) |
| Sept 2001 | - | $42.37 M(-2.1%) |
| June 2001 | - | $43.27 M(-12.3%) |
| Mar 2001 | - | $49.32 M(-9.8%) |
| Dec 2000 | $9.58 M(+10.9%) | $54.68 M |
| Dec 1999 | $8.64 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual current assets year-on-year change?
- What is Rigel Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly current assets year-on-year change?
What is Rigel Pharmaceuticals annual total current assets?
The current annual current assets of RIGL is $99.27 M
What is the all time high annual current assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total current assets is $302.46 M
What is Rigel Pharmaceuticals annual current assets year-on-year change?
Over the past year, RIGL annual total current assets has changed by -$16.64 M (-14.35%)
What is Rigel Pharmaceuticals quarterly total current assets?
The current quarterly current assets of RIGL is $106.47 M
What is the all time high quarterly current assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total current assets is $302.46 M
What is Rigel Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, RIGL quarterly total current assets has changed by +$11.44 M (+12.04%)